Quanzhou Fengze District Xiangshang Network Technology Co., Ltd. – Trademark Portfolio
Entity Type: 99
Quanzhou Fengze District Xiangshang Network Technology Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 33 (Wine & Spirits) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include ZOONE. The owner is based in Quanzhou City Fujian Province.
Rm703,Unit1,Bldg 1 Baoxiu Phase II
No.20Tonggang West Str,Fengze Dist
Quanzhou City Fujian Province 362000 , CN
Showing of trademarks Trademarks
Trademark Classifications
Quanzhou Fengze District Xiangshang Network Technology Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Frequently Asked Questions
How many trademarks does Quanzhou Fengze District Xiangshang Network Technology Co., Ltd. have?
Quanzhou Fengze District Xiangshang Network Technology Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does Quanzhou Fengze District Xiangshang Network Technology Co., Ltd. file in?
Quanzhou Fengze District Xiangshang Network Technology Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 33 (Wine & Spirits). Class 33 covers alcoholic beverages (except beers).
What are Quanzhou Fengze District Xiangshang Network Technology Co., Ltd.'s most well-known trademarks?
Quanzhou Fengze District Xiangshang Network Technology Co., Ltd.'s registered trademark portfolio includes well-known marks such as ZOONE. These are among 1 currently registered trademark in the portfolio.
What is Quanzhou Fengze District Xiangshang Network Technology Co., Ltd.'s trademark registration success rate?
Quanzhou Fengze District Xiangshang Network Technology Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.